An updated patent review of GLP-1 receptor agonists (2020-present)

.

Source: Expert Opinion on Therapeutic Patents - October 23, 2023 Category: Drugs & Pharmacology Authors: Weiwen LuZhongbo ZhouNeng JiangJing Hana School of Pharmacy, Youjiang Medical University for Nationalities, Baise, Guangxi, PR Chinab Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, PR Chinac School of Chemistry & Ma Source Type: research